pmc logo imageJournal ListSearchpmc logo image
Logo of cvmNow Published as Trials.BioMed Central web siteSearch.Manuscript submission.Registration.Journal front page.
Other Issues:  previous | next | latest | archive
Volume 1(3);  2000
Commentaries
Beta-Adrenergic gene therapy for cardiovascular disease
Andrea D Eckhart and Walter J Koch
Curr Control Trials Cardiovasc Med. 2000; 1(3): 131–134. Published online 2000 October 20. doi: 10.1186/cvm-1-3-131.
PMCID: PMC59618
Debate: The potential role of estrogen in the prevention of heart disease in women after menopause
Jacques E Rossouw
Curr Control Trials Cardiovasc Med. 2000; 1(3): 135–138. Published online 2000 October 20. doi: 10.1186/cvm-1-3-135.
PMCID: PMC59619
Debate: The potential role of estrogen in the prevention of heart disease in women after menopause
Rebecca R Johnson and Mary E Sweeney
Curr Control Trials Cardiovasc Med. 2000; 1(3): 139–142. Published online 2000 December 4. doi: 10.1186/cvm-1-3-139.
PMCID: PMC59620
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Ale Algra and Jan van Gijn
Curr Control Trials Cardiovasc Med. 2000; 1(3): 143–145. Published online 2000 November 30. doi: 10.1186/cvm-1-3-143.
PMCID: PMC59615
Debate: Should the elderly receive thrombolytic therapy, or primary angioplasty, for acute myocardial infarction? The case for primary angioplasty
Vincent S DeGeare and Cindy L Grines
Curr Control Trials Cardiovasc Med. 2000; 1(3): 146–149. Published online 2000 December 4. doi: 10.1186/cvm-1-3-146.
PMCID: PMC59621
Debate: Should the elderly receive thrombolytic therapy or primary angioplasty?
Harvey D White
Curr Control Trials Cardiovasc Med. 2000; 1(3): 150–154. Published online 2000 December 4. doi: 10.1186/cvm-1-3-150.
PMCID: PMC59616
Reviews
Exercise training in heart failure
Andrew JS Coats
Curr Control Trials Cardiovasc Med. 2000; 1(3): 155–160. Published online 2000 November 15. doi: 10.1186/cvm-1-3-155.
PMCID: PMC59617
Are statins anti-inflammatory?
Gavin J Blake and Paul M Ridker
Curr Control Trials Cardiovasc Med. 2000; 1(3): 161–165. Published online 2000 November 30. doi: 10.1186/cvm-1-3-161.
PMCID: PMC59622
What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
Jon Kobashigawa
Curr Control Trials Cardiovasc Med. 2000; 1(3): 166–171. Published online 2000 December 4. doi: 10.1186/cvm-1-3-166.
PMCID: PMC59623
Research
Design of a randomized controlled trial of comprehensive rehabilitation in patients with myocardial infarction, stabilized acute coronary syndrome, percutaneous transluminal coronary angioplasty or coronary artery bypass grafting: Akershus Comprehensive Cardiac Rehabilitation Trial (the CORE Study)
Cornel Pater, Carl Ditlef Jacobsen, Arnfinn Rollag, Leiv Sandvik, Jan Erikssen, and Else Karin Kogstad
Curr Control Trials Cardiovasc Med. 2000; 1(3): 177–183. Published online 2000 November 29. doi: 10.1186/cvm-1-3-177.
PMCID: PMC56205
Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trial [ISRCTN19943732]
Andrew Bradford and Kennedy Lees
Curr Control Trials Cardiovasc Med. 2000; 1(3): 184–190. Published online 2000 December 4. doi: 10.1186/cvm-1-3-184.
PMCID: PMC56206
Other Issues:  previous | next | latest | archive
Articles from Current Controlled Trials in Cardiovascular Medicine are provided here courtesy of
BioMed Central